Citations 1
Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancer
Kiiski, Johanna I. , Pelttari, Liisa M. , Khan, Sofia , Freysteinsdóttir, Edda Sigríður, Reynisdóttir, Inga , Hart, Steven N. , Shimelis, Hermela , Vilske, Sara, Kallioniemi, Anne , Schleutker, Johanna , Leminen, Arto , Blomqvist, Carl , Barkardóttir, Rósa B. , Aittomäki, Kristiina , Nevanlinna, Heli , Bützow, Ralf C. , Couch, Fergus J. , Pelttari, L M , Nevanlinna, H , Schleutker, Johanna , Hart, Steven N , Shimelis, Hermela
Proceedings of the National Academy of Sciences | October 6, 2014 | Volume: 111 | Issue: 42 | Pages: 15172-15177
Significance The major portion of hereditary breast cancer still remains unexplained, and many susceptibility loci are yet to be found. Exome sequencing of 24 high-risk familial BRCA1/2 -negative breast cancer patients and further genotyping of a large sample set of breast/ovarian cancer cases and controls was used to discover previously unidentified susceptibility alleles and genes. A significant association of a FANCM nonsense mutation with breast cancer, especially triple-negative breast cancer, identifies FANCM as a breast cancer susceptibility gene. Identification of such risk alleles is expected to improve cancer risk assessment for breast cancer patients and families, and may lead to improvements in the prevention, early diagnosis, and treatment of cancer.